Tysabri has 14,000 patients a year after re-launch
July 23 2007
An estimated 14,000 patients across the globe are currently taking Elan and Biogen IDECs multiple sclerosis treatment Tysabri, a year ...
Your Email Address: *
Recipient(s) Email Address: *
(Separate multiple e-mail addresses with commas. Limited to 20 addresses.)
The e-mail address(es) that you supply to use this service will only be used to send the requested article.